Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Matsui, Y.
Right arrow Articles by Arai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, Y.
Right arrow Articles by Arai, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 32:530-535 (2002)
© 2002 Foundation for Promotion of Cancer Research

Artificial Neural Network Analysis for Predicting Pathological Stage of Clinically Localized Prostate Cancer in the Japanese Population

Yoshiyuki Matsui1, Shin Egawa3, Chotatsu Tsukayama2, Akito Terai1, Sadahito Kuwao4, Shiro Baba3 and Yoichi Arai5,+

Departments of 1 Urology and 2 Pathology, Kurashiki Central Hospital, Kurashiki, Okayama, Departments of 3 Urology and 4 Pathology, Kitasato University School of Medicine, Sagamihara, Kanagawa and 5 Department of Urology, Tohoku University, School of Medicine, Sendai, Japan

Background: Although prostate cancer has been prevalent in Japan, there has been no particular model for predicting the pathological stage in the Japanese population. We examined whether artificial neural network analysis (ANNA), which is a relatively new diagnostic tool in prostate cancer, can be one of the predictive methods for predicting organ confinement, compared with the traditional logistic regression model, in the Japanese population for the first time.

Methods: The study population comprised 178 men who underwent radical prostatectomy at our institutions between October 1992 and May 1999. As additional pretreatment parameters to the preoperative serum PSA level, clinical TNM classification and biopsy Gleason score, the percentage of number of cores exhibiting traces of tumor, maximum tumor length in biopsy cores, PSA density and patient age were used. The predictive ability of ANNA with several parameters for a set of 36 randomly selected test data was compared with those of logistic regression analysis and ‘Partin Tables’ by area under the receiver operating characteristics (ROC) curve analysis.

Results: Of 178 patients, 97 (54.5%) had organ-confined disease but 81 (45.5%) had locally advanced disease. With three parameters, the area under the ROC curve of ANNA (0.825 ± 0.071) was larger than those for logistic regression (0.782 ± 0.079) and Partin Tables (0.756 ± 0.087), but not to a significant extent (P = 0.690 and 0.541). Although the expansion of the parameters did not increase the difference in area under the ROC curve between the best ANNA and logistic regression (0.899 ± 0.053 and 0.873 ± 0.065, respectively), the difference between the best ANNA and Partin Tables did not reach but approached statistical significance (P = 0.157).

Conclusion: Although more modeling optimization is necessary to improve the predictive accuracy and generalizability of ANNA, we suggest that there is the possibility for this new predictive method to evolve in the analysis of clinical staging of prostate cancer.

+ For reprints and all correspondence: Yoshiyuki Matsui, Department of Urology, Kurashiki Central Hospital, 1–1–1 Miwa, Kurashiki 710, Japan. E-mail: ym7856@kchnet.or.jp.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Diabetes and Vascular Disease ResearchHome page
M. Anselmino, K. Malmberg, L. Ryden, and J. Ohrvik
A gluco-metabolic risk index with cardiovascular risk stratification potential in patients with coronary artery disease
Diabetes and Vascular Disease Research, April 1, 2009; 6(2): 62 - 70.
[Abstract] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. Hara, K. Honda, M. Shitashige, M. Ono, H. Matsuyama, K. Naito, S. Hirohashi, and T. Yamada
Mass Spectrometry Analysis of the Native Protein Complex Containing Actinin-4 in Prostate Cancer Cells
Mol. Cell. Proteomics, March 1, 2007; 6(3): 479 - 491.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Y. Matsui, N. Utsunomiya, K. Ichioka, N. Ueda, K. Yoshimura, A. Terai, and Y. Arai
The Use of Artificial Neural Network Analysis to Improve the Predictive Accuracy of Prostate Biopsy in the Japanese Population
Jpn. J. Clin. Oncol., October 1, 2004; 34(10): 602 - 607.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Y.-C. Ou, J.-T. Chen, C.-L. Cheng, H.-C. Ho, and C.-R. Yang
Radical Prostatectomy for Prostate Cancer Patients with Prostate-specific Antigen >20 ng/ml
Jpn. J. Clin. Oncol., November 1, 2003; 33(11): 574 - 579.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.